DRIVIN G ROWTH - Dr. Reddy's

1995
Established: Reddy-
Biomed; our joint
venture in Russia
1992
Entered: Russia; our single
largest international market
1998
Acquired: Dicynene, Styptovit,
Styptochrome and Styptomet to
enter styptics; Doxt, to strengthen
antibiotic portfolio
1997
Acquired: Clamp and Riflux;
to strengthen antibiotic and
antacid portfolio; Becelac, entry
into multivitamin segment
2001
Acquired: Senquel, Stolin, Clohex, S-Flo,
Metrohex, and in-licensed Fittydent in
dental care segment; propelled to No. 1
in this segment in India
Divisionalised: Field force to reinforce
therapy and brand focus
Established: Kunshan Rotam Reddy
Pharmaceutical Co. Ltd., our joint
venture in China
2000
Acquired: Deviprost, Dinoripe and PG
Tab; to strengthen women's healthcare
portfolio
Established: S-Team, a Continuing
Medical Education initiative for medical
practitioners
1999
Acquired: India based American
Remedies Ltd.; strengthened
dermatology, gastro-intestinal and
respiratory portfolios; marks entry
into naturals
2001
Expanded: Presence in Latin
America to 11 countries in this
region
2000
Expanded: Presence in Africa,
to eight countries in this
region
1998
Launched: Velocit, a pregnancy
test kit; our foray into
women’s healthcare in India
1997
Launched: Reclide, our first
Gliclazide drug; currently the
No. 1 in this segment in India
1996
Launched: Nise, a Nimusilide drug;
currently No. 1 in this segment in
India
1995
Entered: Asia; currently present in 10
countries in this region
1994
Launched: Stamlo, an Amlodipine drug; currently No. 1
in this segment in India
Entered: Eastern Europe and CIS; currently present
in 10 countries in these regions